According to a new report, published by KBV research, The Global Nerve Monitoring Devices Market size is expected to reach $1.8 billion by 2030, rising at a market growth of 5.2% CAGR during the forecast period.
The Electroencephalogram (EEG) segment is leading the Global Nerve Monitoring Devices Market, by Technology in 2022 thereby, achieving a market value of $1.2 billion by 2030. Electroencephalogram (EEG) is a medical test that measures and records the brain's electrical activity over time. It is a non-invasive and valuable diagnostic tool used in neurology, psychiatry, and other medical fields to assess brain function. EEG helps doctors diagnose and monitor various neurological conditions and disorders, including epilepsy, sleep disorders, and certain brain injuries. This is a result of its extensive clinical applications in neurological disorders. In addition, this modality can reveal brain activity in milliseconds in real time, offering greater precision.
The Electrodes segment is showcasing a CAGR of 5.5% during (2023 - 2030). Electrodes used in nerve monitoring devices are typically connected to amplifiers and signal processing units, which amplify and process the detected electrical signals before displaying them on the monitoring equipment. The choice of electrode type depends on factors such as the type of surgery, the depth at which the nerves are located, and the specific signals that need to be recorded.
The North America region dominated the Global Nerve Monitoring Devices Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $747 Million by 2030. The Europe market is anticipated to grow at a CAGR of 5% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 6.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/nerve-monitoring-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, NuVasive, Inc., Natus Medical Inc., Neuspera Medical, Inc., Brainlab AG, Checkpoint Surgical, Inc., Cadwell Industries, Inc., Compumedics Limited, Magstim EGI (Magstim, Inc.), and Nihon Kohden Corporation.
By Technology
By Product
By Geography
Companies Profiled
Unique Offerings 
